[Preliminary findings on the use of pargyline in the management of systemic arterial hypertension].
Explore the source record for details and available documents.
SEARCH · PubMed Health
Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Because of the close relation between sodium (Na) and calcium (Ca) tubular reabsorption, restriction of sodium intake has been proposed in hypercalciuric stone formers. We simultaneously measured urinary concentrations of both ions in 30 recurrent stone formers (19 male, 11 female, mean age 40,8 +/- 10,2 years) with fasting hypercalciuria, before and after reduction of calciuria using long-term thiazide (TZ) treatment associated with moderate restriction of calcium intake, without concomitant Na restriction. No recurrence of stones was observed in this group with a 12 to 49 month follow-up. UCa strongly correlated with UNa in both conditions. However, UCa significantly decreased with TZ (128 +/- 32 vs 73 +/- 26 mumol/kg/day, p less than 0.001), whereas neither UNaV (190 +/- 60 vs 202 +/- 57 mmol/day) nor diuresis significantly varied. We conclude that calciuria can be lowered without reduction in Na intake in hypercalciuric stone formers controlled by thiazide treatment.